News Sentiment

ROVI sentiment intelligence

Laboratorios Farmaceuticos Rovi, S.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 3 relevant articles
Exchange VIE Austria
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 55.95 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

66/100 classification confidence.

Company focus 3

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.5% over one week, -4.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

There's A Lot To Like About Laboratorios Farmaceuticos Rovi's (BME:ROVI) Upcoming €0.777114 Dividend

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 66/100 classification
One-week reaction -1.5% Price digesting
Trend fit Trend inactive -4.4% over four weeks
Fair value -12.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 3
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 3
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
marketscreener.com 2
simplywall.st 1

Event Lens

What the news is about

Classified themes
Market update 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-3 of 3